IceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners’ Virtual Healthcare Company Showcase
CAESAREA, Israel, May 20, 2024 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure” or the “Company”), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced the Company’s CEO, Eyal Shamir, will present via a fireside chat at the A.G.P / Alliance Global Partners‘ Virtual Healthcare Company Showcase on Tuesday, May 21, 2024, at 8:20am EDT. Investors may register to view the presentation at the virtual conference through the following LINK.